METASTATIC COLORECTAL CANCER (CRC)
Clinical trials for METASTATIC COLORECTAL CANCER (CRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (CRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets advanced colon cancer
Disease control Not yet recruitingThis study tests a combination of four drugs (irinotecan liposome, capecitabine, bevacizumab, and camrelizumab) as a second or later treatment for people with metastatic colorectal cancer that has spread. The goal is to see if this mix can slow or stop cancer growth. The trial pl…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New hope for advanced colon cancer: drug cocktail plus radiation tested
Disease control Not yet recruitingThis study is for people with metastatic colorectal cancer that has spread to a few spots (like the liver or lungs) and hasn't responded to at least two prior treatments. It tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) plus targeted radiation to the…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New drug combo aims to improve second-line treatment for advanced colorectal cancer
Disease control Not yet recruitingThis study tests whether a liposomal (encapsulated) form of irinotecan combined with other drugs works better than standard irinotecan for people with metastatic colorectal cancer that has progressed after first-line treatment. About 408 adults aged 18-75 will be randomly assigne…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2, PHASE3 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New hope for advanced colon cancer: 4-drug combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus bevacizumab and chemotherapy as a first treatment for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to see if this mix shrinks tumors and how safe…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New combo aims to control advanced colorectal cancer
Disease control Not yet recruitingThis study tests a new drug combination (fruquintinib plus trifluridine/tipiracil) against a standard combo (bevacizumab plus trifluridine/tipiracil) in people with advanced colorectal cancer that has not responded to standard chemotherapy. About 292 adults aged 18-75 will take p…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy targets tough gut cancers in major trial
Disease control Not yet recruitingThis study tests a new drug called SSGJ-706 combined with standard treatments for people with advanced stomach, colon, pancreatic, or esophageal cancers that cannot be removed by surgery. The goal is to see if the combination is safe and helps shrink or control tumors. About 300 …
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New combo therapy targets hard-to-treat colon cancer
Disease control Not yet recruitingThis early-phase study tests whether adding the experimental drug SAR445877 to standard chemotherapy (FOLFOX6) and a targeted therapy (bevacizumab) is safe for people with a specific type of advanced colorectal cancer called microsatellite stable (MSS). The study will include abo…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New hope for advanced colorectal cancer: rechallenge therapy tested
Disease control Not yet recruitingThis study tests if giving a combination of two drugs (irinotecan and cetuximab) again can work better than the current standard treatment for people with advanced colorectal cancer that has spread. The study includes 150 adults whose cancer has gotten worse after earlier treatme…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italia Meridionale • Aim: Disease control
Last updated May 11, 2026 20:39 UTC